Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma

por Li, Peng, Liu, Hongliang, Zhang, Zhiqiang, Lv, Xiaodong, Wang, Huijuan, Ma, Jie, Ma, Zhiyong, Qu, Xiujuan, Teng, Yue-e
Publicado no Med Sci Monit (2018)

Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells

por Wang, Qian, Cheng, Yu, Wang, Yan, Fan, Yibo, Li, Ce, Zhang, Ye, Wang, Yiding, Dong, Qian, Ma, Yanju, Teng, Yue-e, Qu, Xiujuan, Liu, Yunpeng
Publicado no BMC Cancer (2017)

Single nucleotide polymorphisms of casitas B-lineage lymphoma proto-oncogene-b predict outcomes of patients with advanced non-small cell lung cancer after first-line platinum based...

por Li, Peng, Liu, Hong-Liang, Zhang, Zhi-Qiang, Lv, Xiao-Dong, Chang, Yu-Xi, Wang, Hui-Juan, Ma, Jie, Ma, Zhi-Yong, Qu, Xiu-Juan, Teng, Yue-e
Publicado no J Thorac Dis (2018)

Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer

por Xin, Xing, Wen, Ti, Gong, Li-Bao, Deng, Ming-Ming, Hou, Ke-Zuo, Xu, Lu, Shi, Sha, Qu, Xiu-Juan, Liu, Yun-Peng, Che, Xiao-Fang, Teng, Yue-E
Publicado no Front Oncol (2020)

Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer

por Qu, Jing-lei, Li, Xin, Qu, Xiu-juan, Zhu, Zhi-tu, Zhou, Li-zhong, Teng, Yue-e, Zhang, Jing-dong, Jin, Bo, Zhao, Ming-fang, Yu, Ping, Liu, Yun-peng
Publicado em 2013

FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis

por Xu, Lu, Shen, Ji-Ming, Qu, Jing-Lei, Song, Na, Che, Xiao-Fang, Hou, Ke-Zuo, Shi, Jing, Zhao, Lei, Shi, Sha, Liu, Yun-Peng, Qu, Xiu-Juan, Teng, Yue-E
Publicado no Ann Transl Med (2021)

Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equiv...

por Xu, Binghe, Zhang, Qingyuan, Sun, Tao, Li, Wei, Teng, Yue’e, Hu, Xichun, Bondarenko, Igor, Adamchuk, Hryhoriy, Zhang, Liangming, Trukhin, Dmytro, Wang, Shusen, Zheng, Hong, Tong, Zhongsheng, Shparyk, Yaroslav, Wang, Qingyu
Publicado no BioDrugs (2021)

Biological and clinical significance of flap endonuclease-1 in triple-negative breast cancer: Support of metastasis and a poor prognosis

por Xu, Lu, Qu, Jing-Lei, Song, Na, Zhang, Ling-Yun, Zeng, Xue, Che, Xiao-Fang, Hou, Ke-Zuo, Shi, Sha, Feng, Zu-Ying, Qu, Xiu-Juan, Liu, Yun-Peng, Teng, Yue-E
Publicado no Oncol Rep (2020)

Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer

por Qu, Jing-lei, Qu, Xiu-juan, Li, Zhi, Zhang, Jing-dong, Liu, Jing, Teng, Yue-e, Jin, Bo, Zhao, Ming-fang, Yu, Ping, Shi, Jing, Fu, Ling-yu, Wang, Zhen-ning, Liu, Yun-peng
Publicado no PLoS One (2015)

YY1 suppresses FEN1 over-expression and drug resistance in breast cancer

por Wang, Jianwei, Zhou, Lina, Li, Zhi, Zhang, Ting, Liu, Wenpeng, Liu, Zheng, Yuan, Yate-Ching, Su, Fan, Xu, Lu, Wang, Yan, Zhou, Xiaotong, Xu, Hong, Hua, Yuejin, Wang, Ying-Jie, Zheng, Li, Teng, Yue-E, Shen, Binghui
Publicado no BMC Cancer (2015)